title: Diagnosis and treatment of acute promyelocytic leukemia.
abstract: Acute promyelocytic leukemia (APL), characterized by a translocation between the promyelocytic leukemia gene (PML) on chromosome 15 and the retinoic acid receptor-alpha (RARalpha) gene on chromosome 17, has become a model for targeted treatment of cancer. Advances in our understanding of the fundamental biology of this disease have led to the development of tools for diagnosis, monitoring of minimal residual disease, and detection of early relapse. Differentiation therapy with all-trans retinoic acid in combination with chemotherapy has significantly improved survival in patients with APL. Moreover, arsenic trioxide, which induces differentiation and apoptosis of APL cells, has become standard treatment for relapsed disease, and its role in the treatment of newly diagnosed APL is under active investigation. The lessons learned from APL have broad applications to other forms of leukemia and to cancer in general, whereby molecularly targeted therapy is directed to specifically defined subgroups.
authors: Leukemia Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. jurcicj@mskcc.org
authors: Joseph G
authors: JG
authors: Jurcic
authors: Steven L
authors: SL
authors: Soignet
authors: And Peter G
authors: AP
authors: Maslak
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000175:diagnosis* / Q000188:drug therapy* / Q000235:genetics; D014178:Translocation, Genetic
chemical_list: D000970:Antineoplastic Agents
references: Blood. 1992 Nov 1;80(9):2176-81
references: 1421389
references: Blood. 1996 Feb 1;87(3):882-6
references: 8562957
references: N Engl J Med. 1999 Apr 1;340(13):994-1004
references: 10099141
references: Blood. 1980 Feb;55(2):253-9
references: 6928105
references: Blood. 1994 Dec 1;84(11):3843-9
references: 7949141
references: Blood. 1997 Aug 1;90(3):1321-5
references: 9242568
references: Haematologica. 2007 Mar;92(3):315-22
references: 17339180
references: Blood. 1996 Aug 1;88(3):1052-61
references: 8704214
references: Blood. 2002 Dec 15;100(13):4298-302
references: 12393590
references: J Clin Oncol. 2001 Sep 15;19(18):3852-60
references: 11559723
references: Nat Genet. 1997 Sep;17 (1):109-13
references: 9288109
references: Leukemia. 2006 Aug;20(8):1393-9
references: 16728984
references: Blood. 2001 Nov 1;98(9):2651-6
references: 11675334
references: Blood. 2002 Jun 1;99(11):4222-4
references: 12010830
references: N Engl J Med. 1991 May 16;324(20):1385-93
references: 1850498
references: Blood. 1997 May 1;89(9):3345-53
references: 9129041
references: Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10173-8
references: 10954752
references: Lancet. 1992 Dec 12;340(8833):1437-8
references: 1360562
references: Blood. 2000 Aug 15;96(4):1287-96
references: 10942370
references: Nature. 1997 May 1;387(6628):43-8
references: 9139820
references: J Exp Med. 2006 Apr 17;203(4):821-8
references: 16549595
references: Blood. 1990 Nov 1;76(9):1704-9
references: 2224119
references: J Clin Invest. 1993 May;91(5):2260-7
references: 8387545
references: Hum Mol Genet. 1999 Sep;8(9):1741-9
references: 10441338
references: J Clin Oncol. 1997 May;15(5):1786-95
references: 9164186
references: Blood. 2004 Feb 15;103(4):1237-43
references: 14576047
references: Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5328-35
references: 15044693
references: Blood. 1988 Aug;72(2):567-72
references: 3165295
references: Blood. 1999 Aug 15;94(4):1192-200
references: 10438706
references: Blood. 2006 May 1;107(9):3469-73
references: 16373661
references: J Clin Oncol. 2006 Dec 20;24(36):5703-10
references: 17116939
references: Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2694-8
references: 1372989
references: Blood. 1997 Aug 1;90(3):1014-21
references: 9242531
references: Crit Rev Oncol Hematol. 2001 Apr;38(1):37-45
references: 11255080
references: N Engl J Med. 1998 Nov 5;339(19):1341-8
references: 9801394
references: J Clin Oncol. 1995 May;13(5):1238-41
references: 7738627
references: Oncologist. 2003;8(2):132-40
references: 12697938
references: Blood. 2000 Aug 15;96(4):1247-53
references: 10942364
references: J Clin Oncol. 2005 Jan 1;23(1):120-6
references: 15534358
references: Leuk Lymphoma. 2006 Jun;47(6):1062-8
references: 16840198
references: J Clin Oncol. 2000 Mar;18(6):1295-300
references: 10715300
references: Leukemia. 2007 Mar;21(3):446-52
references: 17205057
references: J Exp Med. 2001 Feb 19;193(4):521-29
references: 11181703
references: Leukemia. 2006 Jan;20(1):35-41
references: 16307026
references: Blood. 2000 Aug 15;96(4):1297-308
references: 10942371
references: J Natl Cancer Inst. 1990 Dec 19;82(24):1932-3
references: 2174466
references: Leukemia. 1995 Jan;9(1):19-24
references: 7531260